Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

542 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party.
Bazarbachi A, Labopin M, Battipaglia G, Djabali A, Passweg J, Socié G, Forcade E, Blaise D, Chevallier P, Orvain C, Cornelissen JJ, Arcese W, Chantepie S, Hashaishi K, El Cheikh J, Medinger M, Esteve J, Nagler A, Mohty M. Bazarbachi A, et al. Among authors: labopin m. Haematologica. 2019 Sep;104(9):e398-e401. doi: 10.3324/haematol.2018.211615. Epub 2019 Feb 21. Haematologica. 2019. PMID: 30792203 Free PMC article. No abstract available.
A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O, Labopin M, Tura S, Arcese W, Iriondo A, Zittoun R, Sierra J, Gorin NC. Ringdén O, et al. Among authors: labopin m. Br J Haematol. 1996 Jun;93(3):637-45. doi: 10.1046/j.1365-2141.1996.d01-1681.x. Br J Haematol. 1996. PMID: 8652385
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E. Gorin NC, et al. Among authors: labopin m. Bone Marrow Transplant. 1996 Jul;18(1):111-7. Bone Marrow Transplant. 1996. PMID: 8832003
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A. Devergie A, et al. Among authors: labopin m. Bone Marrow Transplant. 1997 Jul;20(1):11-9. doi: 10.1038/sj.bmt.1700844. Bone Marrow Transplant. 1997. PMID: 9232250
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O, Labopin M, Gorin NC, Meloni G, Blaise D, Reiffers J, Carlson K, Fouillard L, Frassoni F. Ringdén O, et al. Among authors: labopin m. Bone Marrow Transplant. 2000 May;25(10):1053-8. doi: 10.1038/sj.bmt.1702409. Bone Marrow Transplant. 2000. PMID: 10828865
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Cahn JY, Labopin M, Sierra J, Blaise D, Reiffers J, Ferrant A, Bergmann L, Visani G, Cornelissen J, De Witte T, Bosi A, Frassoni F, Gorin NC. Cahn JY, et al. Among authors: labopin m. Br J Haematol. 2000 Aug;110(2):308-14. doi: 10.1046/j.1365-2141.2000.02178.x. Br J Haematol. 2000. PMID: 10971386 Free article.
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission.
Locatelli F, Labopin M, Ortega J, Meloni G, Dini G, Messina C, Yaniv I, Fagioli F, Castel V, Shaw PJ, Ferrant A, Pession A, Sociè G, Frassoni F; European Blood and Marrow Transplantation Acute Leukemia Working Party. Locatelli F, et al. Among authors: labopin m. Blood. 2003 Feb 15;101(4):1611-9. doi: 10.1182/blood-2002-03-0764. Epub 2002 Oct 10. Blood. 2003. PMID: 12393725 Free article.
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.
Rocha V, Labopin M, Gluckman E, Powles R, Arcese W, Bacigalupo A, Reiffers J, Iriondo A, Ringdén O, Ruutu T, Frassoni F; Acute Leukemia Working Party of the European Blood and Marrow Transplant Registry. Rocha V, et al. Among authors: labopin m. J Clin Oncol. 2002 Nov 1;20(21):4324-30. doi: 10.1200/JCO.2002.11.058. J Clin Oncol. 2002. PMID: 12409331
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow.
Gorin NC, Labopin M, Rocha V, Arcese W, Beksac M, Gluckman E, Ringden O, Ruutu T, Reiffers J, Bandini G, Falda M, Zikos P, Willemze R, Frassoni F; European Cooperative Group for Blood and Marrow Transplantation Acute Leukemia Working Party. Gorin NC, et al. Among authors: labopin m. Blood. 2003 Oct 15;102(8):3043-51. doi: 10.1182/blood-2003-03-0665. Epub 2003 Jun 26. Blood. 2003. PMID: 12829583 Free article.
542 results